Jeniffer Mathews: Catherine Price is a natural on the piano. She has Type One Diabetes but doesn't let it slow her down. She keeps her disease in tight control.

Catherine Price: It's a tightrope and if you're off on either side there are consequences.

Jeniffer Mathews: Catherine has it better than many diabetics, thanks to a two- week experimental treatment she received shortly after diagnosis. Researchers say HOKT-3 GAMMA -1 is the first short-term therapy that appears to slow progression of the disease.

Kevan Herold: We know that it inactivates the cells that are responsible for the development of type 1 diabetes. So somehow or another, it turns them off so that they don't continue to destroy the insulin-producing cells.

Jeniffer Mathews: While it's unclear how long the effects will last, two years later Catherine is producing more of her own insulin than she probably would have without the treatment.

Kevan Herold: People who control their diabetes very well will have a much lower risk of developing the long-term complications, such as eye disease, kidney disease and others. And if you're able to make some of your own insulin, it's a lot easier to do that.

Catherine Price: I'm just really happy about it. Because if I didn't have that, I can't even imagine how hard it would be

Jeniffer Mathews: This is Jeniffer Mathews reporting.
Jeniffer Mathews: Catherine Price is a natural on the piano. She has Type One Diabetes but doesn't let it slow her down. She keeps her disease in tight control.

Catherine Price: It's a tightrope and if you're off on either side there are consequences.

Jeniffer Mathews: Catherine has it better than many diabetics, thanks to a two- week experimental treatment she received shortly after diagnosis. Researchers say HOKT-3 GAMMA -1 is the first short-term therapy that appears to slow progression of the disease.

Kevan Herold: We know that it inactivates the cells that are responsible for the development of type 1 diabetes. So somehow or another, it turns them off so that they don't continue to destroy the insulin-producing cells.

Jeniffer Mathews: While it's unclear how long the effects will last, two years later Catherine is producing more of her own insulin than she probably would have without the treatment.

Kevan Herold: People who control their diabetes very well will have a much lower risk of developing the long-term complications, such as eye disease, kidney disease and others. And if you're able to make some of your own insulin, it's a lot easier to do that.

Catherine Price: I'm just really happy about it. Because if I didn't have that, I can't even imagine how hard it would be

Jeniffer Mathews: This is Jeniffer Mathews reporting.